what is a normal dose of semaglutide Dosing Guide (2026): Doses, Chart & Max oral dose of semaglutide for

On April 1, 2026, the FDA approved orforglirpon under the brand name Foundayo to reduce excess body weight and maintain weight reduction long term in: Adults with obesity Adults with overweight and at least one weight-related medical condition Like other GLP-1s for weight loss, orforglipron is also indicated in combination with a reduced-calorie diet and increased physical activity

Benefits: Improves skin texture and reduces dark spots, blemishes, and scars

So thin at any cost

Wegovy is MHRA-approved in the UK for chronic weight management, and many patients who switch continue to lose weight effectively after the transition